{"schema_version":"secwatch.filing_event.v1","accession":"0001615219-24-000076","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2024-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.782783+00:00","generated_at":"2026-05-31T09:01:19.335436+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Salarius raises ~$1.5M to meet Nasdaq minimum equity requirement after being below $2.5M threshold","bullets":["As of June 30, 2024, stockholders' equity was $2,375,353, below Nasdaq's $2.5M minimum.","Sold 564,730 shares for gross proceeds of ~$1.5M via at-the-market offering to restore compliance.","Company believes it now complies with Nasdaq Listing Rule 5550(b)(1) after the financing.","Nasdaq will monitor; if next 10-Q shows non-compliance, common stock may be delisted."],"urls":{"canonical":"https://secwatch.observer/filing/0001615219-24-000076","json":"https://secwatch.observer/filing/0001615219-24-000076.json","markdown":"https://secwatch.observer/filing/0001615219-24-000076.md","text":"https://secwatch.observer/filing/0001615219-24-000076.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000161521924000076/0001615219-24-000076-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000161521924000076/flks-20240813.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:01:19.335436+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}